Navigation Links
ViroPharma to Present at Two May Healthcare Conferences

EXTON, Pa., May 7 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the Bank of America/Merrill Lynch 2009 Healthcare Conference at 8:00 A.M. ET on Wednesday, May 13, 2009. The conference is being held at the Palace Hotel in New York City.

ViroPharma also announced that Charles Rowland, vice president and chief financial officer of ViroPharma will present at the Deutsche Bank 2009 Healthcare Conference at NOON ET on Monday, May 18, 2009. The conference is being held at the InterContinental Hotel in Boston.

ViroPharma's presentations will be webcast live for investors through and available for a period of 14 days following the conferences.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains. ViroPharma commercializes Cinryze(TM) (C1 esterase inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package inserts at ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile.

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, The company encourages investors to consult these sections for more information on ViroPharma and our business.

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ViroPharma to Present at the Maxim Group First Annual Growth Conference
2. ViroPharma to Present at the UBS Global Life Sciences Conference
3. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
4. ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
5. ViroPharma to Present at the 26th Annual JP Morgan Healthcare Conference
6. ViroPharma Augments Senior Management
7. ViroPharma Provides Update on Vancocin(R)
8. Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
9. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
10. ViroPharma Incorporated Reports First Quarter 2008 Financial Results
11. ViroPharma to Release 2008 Second Quarter Financial Results on July 30, 2008
Post Your Comments:
(Date:11/30/2015)... , ... November 30, 2015 , ... ... engine optimization companies, announced today that it has officially launched a sleek, mobile-ready ... SEO, explained that his company’s new website clearly outlines the benefits that its ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... Beard and Brooke Bennett are collaborating with brands across various categories through traditional ... influential figures make up an elite group of Gold Medal Moms who can ...
(Date:11/30/2015)... Cary, NC (PRWEB) , ... November 30, 2015 , ... ... and corporate support as they play for the chance to represent the United States. ... fans the opportunity to be a part of their journey in addition to offering ...
(Date:11/30/2015)... ... December 01, 2015 , ... The Turks & Caicos Islands has ... leading digital news sites highlighting Caribbean destinations, has published five reasons to visit the ... North America shivers under chilly grey skies or worse, it's typically a balmy 80 ...
(Date:11/30/2015)... ... December 01, 2015 , ... The National Association ... inductee into its VIP Woman of the Year Circle. She is recognized with ... organization exclusively for professional women, boasting 850,000 members and over 200 operating Local ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... and BASEL, Switzerland , Dec. ... (Upsher-Smith), through its wholly-owned UK subsidiary Proximagen Ltd., ... of a novel, oral small molecule inhibitor of Vascular ... be effective in the treatment of inflammatory disease. The ... --> --> Under ...
(Date:11/30/2015)... -- Researchers have developed software for the Microsoft Kinect ... for motion, positioning and beam adjustment immediately before X-ray ... the annual meeting of the Radiological Society of ... Don , M.D., associate professor of radiology at Mallinckrodt ... St. Louis, Mo. "This technology ...
(Date:11/30/2015)... , Dec. 1, 2015 Express Scripts (NASDAQ: ... (NASDAQ: IMMY ) to drive access to a low-cost ... treatment of toxoplasmosis that has been recently priced out of ... weakened immune systems. --> --> ... and leucovorin (a form of folic acid) for $1 per capsule ...
Breaking Medicine Technology: